Stakeholder driven development of a multi-criteria decision analysis tool for purchasing off-patent pharmaceuticals in Kuwait.
Ali Hadi AbdullahAnke-Peggy HoltorfMaryam Al-HussainiJacinthe LemayMaryam AlowayeshZoltán KalóPublished in: Journal of pharmaceutical policy and practice (2019)
A MCDA model was successfully adapted to the Kuwait decision context by a group of Kuwaiti pharmacists from a broad range of institutions. The participants agreed with the approach and considered it suitable to improve the transparency and consistency of decision making for off-patent pharmaceuticals in Kuwait. A pilot implementation project was proposed.